npj Precision Oncology

Article	Citations
KMT2C inactivation leads to PTEN downregulation and tolerance to DNA damage during cell cycle progression	336
MYSM1 promotes lung adenocarcinoma progression via TRAF2/3-mediated activation of MAPK and non-canonical NF-κB pathways	173
Sub-regional radiomics combining multichannel 2-dimensional or 3-dimensional deep learning for predicting neoadjuvant chemo-immunotherapy response in esophageal squamous cell carcinoma: a multicenter	141
Improved prediction of MAPKi response duration in melanoma patients using genomic data and machine learning	133
Multi-modal characterization of metabolic and immune gene clusters in adrenocortical carcinoma treatment	132
Development and testing of a polygenic risk score for breast cancer aggressiveness	126
Patient-level proteomic network prediction by explainable artificial intelligence	120
Analyses of canine cancer mutations and treatment outcomes using real-world clinico-genomics data of 2119 dogs	117
Tumor break load quantitates structural variant-associated genomic instability with biological and clinical relevance across cancers	111
Developing survival prediction models in colorectal cancer using epigenome-wide DNA methylation data from whole blood	92
Author Correction: An automated deep learning pipeline for EMVI classification and response prediction of rectal cancer using baseline MRI: a multi-centre study	80
Circulating tumor DNA in ALK-positive anaplastic large cell lymphoma: a proof-of-concept study	74
Exosome- transported FER inhibitor suppresses progression of diffuse large B-cell lymphoma via regulating AJUBA/Hippo axis	73
Genome-wide analyses reveals an association between invasive urothelial carcinoma in the Shetland sheepdog and NIPAL1	70
Imaging and AI based chromatin biomarkers for diagnosis and therapy evaluation from liquid biopsies	69
The dynamic immune behavior of primary and metastatic ovarian carcinoma	63
Complement activation in tumor microenvironment after neoadjuvant therapy and its impact on pancreatic cancer outcomes	62
Grading of lung adenocarcinomas with simultaneous segmentation by artificial intelligence (GLASS-AI)	62
Co-targeting KRAS G12C and EGFR reduces both mutant and wild-type RAS-GTP	62
Benchmarking progression-free survival ratio as primary endpoint in precision oncology clinical trials	62
BRAF v600E–mutant cancers treated with vemurafenib alone or in combination with everolimus, sorafenib, or crizotinib or with paclitaxel and carboplatin (VEM-PLUS) study	61
A perspective on life-cycle health technology assessment and real-world evidence for precision oncology in Canada	60
Interferon signaling and ferroptosis in tumor immunology and therapy	58
Constitutional mismatch repair deficiency mimicking Lynch syndrome is associated with hypomorphic mismatch repair gene variants	57
Assessment of TROP2, CEACAM5 and DLL3 in metastatic prostate cancer: Expression landscape and molecular correlates	56

A protein-encoding CCDC7 circular RNA inhibits the progression of prostate cancer by up-regulating FLRT3	56
Mucin-1: a promising pan-cancer therapeutic target	55
Artificial intelligence-driven prediction of lymph node metastasis in T1 esophageal squamous cell carcinoma using whole slide images	55
An automated deep learning pipeline for EMVI classification and response prediction of rectal cancer using baseline MRI: a multi-centre study	53
Barriers and opportunities in pancreatic cancer immunotherapy	51
Multiregional transcriptomic profiling provides improved prognostic insight in localized non-small cell lung cancer	49
Erigoster B targeting DECR1 induces ferroptosis of breast cancer cells via promoting phosphatidylcholine/arachidonic acid metabolism	49
Enhanced efficacy of ipilimumab plus nivolumab in angiogenic subtypes of metastatic clear-cell renal cell carcinoma	47
Collagen disorder architecture features are associated with clinical, molecular, genetic factors and survival outcomes in colon cancer	46
Histological transformation to gliosarcoma with combined BRAF/MEK inhibition in BRAF V600E mutated glioblastoma	46
Pan-cancer molecular tumor board experience with biomarker-driven precision immunotherapy	46
Prolonged response to dual immune checkpoint blockade in patients with advanced solid tumors: a case series	45
Genomic and transcriptomic analyses identify distinctive features of triple-negative inflammatory breast cancer	45
Machine learning model for predicting tertiary lymphoid structures and treatment response in triple-negative breast cancer	45
Single-cell landscape of bronchoalveolar immune cells in patients with immune checkpoint inhibitor-related pneumonitis	45
Baseline biomarkers of efficacy and on-treatment immune-profile changes associated with bempegaldesleukin plus nivolumab	43
ECM-based molecular subtypes define prognostic, EMT status, and therapeutic diversity in IDH-mutant gliomas	43
Discovery of prognostic lncRNAs in colorectal cancer using spatial transcriptomics	43
User-centered design approach to visualize PROMs for molecular tumor boards	42
Real-world experience of Molecular Tumour Boards for clinical decision-making for cancer patients	42
TRIM65 regulates glucose metabolic reprogramming to promote glioma cell proliferation via ubiquitination and degradation of AMPK	41
Stage-dependent spatial distribution and prognostic value of CD8+ tissue-resident memory T cells in NSCLC	41
PD-1 blockade potentiates neoadjuvant chemotherapy in NSCLC via increasing CD127+ and KLRG1+ CD8 T cells	40
m6A reader IGF2BP2-stabilized lncRNA LHX1-DT inhibits renal cell carcinoma (RCC) cell proliferation and invasion by sponging miR-590-5p	40
Comparative cost analysis of a diagnostic multi-omics platform for decision support in advanced cancer – results from the Tumor Profiler Melanoma project	39
A universal immunohistochemistry analyzer for generalizing AI-driven assessment of immunohistochemistry across immunostains and cancer types	38
Targeting Nrf2/PHKG2 axis to enhance radiosensitivity in NSCLC	38
An international multi-institutional validation study of the algorithm for prostate cancer detection and Gleason grading	37
Venetoclax resistance in preclinical KMT2A-rearranged acute lymphoblastic leukemia models is characterized by high inter- and intra-model heterogeneity	37
Establishing predictive machine learning models for drug responses in patient derived cell culture	37
Self-supervised attention-based deep learning for pan-cancer mutation prediction from histopathology	37
First-in-human prospective trial of sonobiopsy in high-grade glioma patients using neuronavigation-guided focused ultrasound	36
Author Correction: Imaging and AI based chromatin biomarkers for diagnosis and therapy evaluation from liquid biopsies	36
Relationship among DDR gene mutations, TMB and PD-L1 in solid tumour genomes identified using clinically actionable biomarker assays	36
Multi-omics machine learning to study host-microbiome interactions in early-onset colorectal cancer	36
A core driver gene set identified based on geMER reveals its potential driver mechanism in pan-cancer	35
Leveraging patient derived models of FGFR2 fusion positive intrahepatic cholangiocarcinoma to identify synergistic therapies	34
Tumor fraction-based prognostic tool for cancer patients referred to early phase clinical trials	34
Novel molecular subtypes of METex14 non-small cell lung cancer with distinct biological and clinical significance	33
AI-driven eyelid tumor classification in ocular oncology using proteomic data	33
Compound heterozygous MSH3 germline variants and associated tumor somatic DNA mismatch repair dysfunction	33
Machine learning algorithms for predicting glioma patient prognosis based on CD163+FPR3+ macrophage signature	32
A large-scale, multi-centre validation study of an AI-empowered blood-based test for multi-cancer early detection	32
Deciphering associations between three RNA splicing-related genetic variants and lung cancer risk	31
In-depth inference of transcriptional regulatory networks reveals NPM1 as a therapeutic ribosomal regulator in MYC-amplified medulloblastoma	31
Selpercatinib combination with the mitochondria-targeted antioxidant MitoQ effectively suppresses RET–mutant thyroid cancer	31
The hegemonic EWSR1::ETS oncoprotein overrules core regulatory circuitry principles in Ewing sarcoma	31
Mediator kinase inhibition impedes transcriptional plasticity and prevents resistance to ERK/MAPK-targeted therapy in KRAS-mutant cancers	31
Progress in personalized immunotherapy for patients with brain metastasis	31
Prediction of homologous recombination deficiency identifies colorectal tumors sensitive to PARP inhibition	30

Enhancing adoptive cell therapy: future strategies for immune cell radioprotection in neuro-oncology	30
ML-based sequential analysis to assist selection between VMP and RD for newly diagnosed multiple myeloma	30
The SMARCA4R1157W mutation facilitates chromatin remodeling and confers PRMT1/SMARCA4 inhibitors sensitivity in colorectal cancer	30
HER3 targeting augments the efficacy of panobinostat in claudin-low triple-negative breast cancer cells	30
Colorectal cancer risk stratification on histological slides based on survival curves predicted by deep learning	29
Plasma proteomic biomarkers predict therapeutic responses in advanced biliary tract cancer patients receiving Camrelizumab plus the GEMOX treatment	29
Deciphering the liver’s role in pancreatic cancer metastasis: pathways and therapeutic approaches	29
Unlocking the potential of TIGIT in enhancing therapeutic strategies for acute myeloid leukemia through combined azacitidine therapy	29
A multimodal fusion system predicting survival benefits of immune checkpoint inhibitors in unresectable hepatocellular carcinoma	29
High clinical actionability of a pan-cancer tissue-based combined DNA and RNA next generation sequencing assay in a diverse Asian population	28
Multiclass machine learning models for molecular subtype identification of pediatric low-grade glioma using bi-institutional MRIs for precision medicine	27
Targeting tumoral heterogeneity in lung cancer: a novel, CT-texture-guided targeted biopsy approach with exome sequencing	27
MDM2 inhibition is associated with the emergence of TP53-altered clonal hematopoiesis	27
A complex phylogeny of lineage plasticity in metastatic castration resistant prostate cancer	26
Potential of pre-diagnostic metabolomics for colorectal cancer risk assessment or early detection	26
Efficacy of PARP inhibitor therapy after targeted BRAF/MEK failure in advanced melanoma	26
Personalized chronotherapy in glioblastoma: integrating circadian profiling and PK–PD modelling to optimize temozolomide timing	26
Fractal analysis of longitudinal MRI for predicting response to neoadjuvant chemotherapy in breast cancer	26
CNTNAP4 signaling regulates osteosarcoma disease progression	26
Deep learning-based quantification of eosinophils and lymphocytes shows complementary prognostic effects in colorectal cancer patients	25
Artificial intelligence-based epigenomic, transcriptomic and histologic signatures of tobacco use in oral squamous cell carcinoma	25
Cancer-related cells and oncosomes in the liquid biopsy of pancreatic cancer patients undergoing surgery	25
Homologous recombination deficiency signatures in gastrointestinal and thoracic cancers correlate with platinum therapy duration	25
Augmented reality microscopy to bridge trust between AI and pathologists	25
Perfusion-based ex vivo culture of frozen ovarian cancer tissues with preserved tumor microenvironment	25
Targeting high-risk MYC-overexpressed osteosarcoma with an Aurora kinase inhibitor:--results from a pilot umbrella trial	25
A multi-cancer early detection blood test using machine learning detects early-stage cancers lacking USPSTF-recommended screening	24
Activation of CD44/PAK1/AKT signaling promotes resistance to FGFR1 inhibition in squamous-cell lung cancer	24
Predicting ROS1 and ALK fusions in NSCLC from H&E slides with a two-step vision transformer approach	24
A patient-designed tissue-engineered model of the infiltrative glioblastoma microenvironment	24
ChemoID-guided therapy improves objective response rate in recurrent platinum-resistant ovarian cancer randomized clinical trial	24
Artificial intelligence-based assessment of PD-L1 expression in diffuse large B cell lymphoma	24
Multi-output prediction of dose–response curves enables drug repositioning and biomarker discovery	24
EPAS1 increases SDHA to inhibit proliferation of multiple myeloma cells by restoring TCA Cycle	24
Transcriptional profiling clarifies a program of enzalutamide extreme non-response in lethal prostate cancer	23
Role of large language models in the multidisciplinary decision-making process for patients with renal cell carcinoma: a pilot experience	23
Personalized prediction of anticancer potential of non-oncology drugs through learning from genome derived molecular pathways	23
PUM1-TRAF3 fusion protein activates non-canonical NF-κB signaling via rescued NIK in biliary tract cancer	23
ALK fusions in the pan-cancer setting: another tumor-agnostic target?	23
Predicting colorectal cancer survival by combined c-reactive protein and tumor immune score	22
Functional cure with single agent olutasidenib in relapsed IDH1/NPM1 co-mutated AML	22
Author Correction: A targetable OSGIN1–AMPK–SLC2A3 axis controls the vulnerability of ovarian cancer to ferroptosis	22
Genetic and oncogenic features of RASGRF fusions	22
Complete morphologic response to gilteritinib in ALK-rearranged acute myeloid leukemia	22
LINE1 insertion into the NACC2 locus disrupts the HDM2 axis and activates lung oncogenic signaling	22
Germline pathogenic variants in DNA repair pathways: a key feature in a significant subset of translocation-associated sarcomas	22
Striking efficacy of a vaccine targeting TOP2A for triple-negative breast cancer immunoprevention	22
Development and interpretation of a multimodal predictive model for prognosis of gastrointestinal stromal tumor	22
ARHGAP4/MYH9/β-catenin/c-Jun positive feedback loop promotes colorectal cancer stemness	22
RICH1 enhances pro-inflammatory TAM infiltration in breast cancer via promoting TRIM21-mediated ubiquitination of RhoA and inhibiting STAT3 phosphorylation	21
Ultrasensitive ctDNA monitoring for organ preservation in patients with locally advanced rectal cancer	21
Co-clinical trial targeting ER, FGFR and CDK4/6 in resistant hormone-positive breast cancer with FGFR alterations	21
Chemokine expression predicts T cell-inflammation and improved survival with checkpoint inhibition across solid cancers	21
Clock pathway inhibitor overcomes tumor immune-exclusion via regulation of fibrocyte differentiation	21
Ligand-receptor interactions combined with histopathology for improved prognostic modeling in HPV-negative head and neck squamous cell carcinoma	21
Multicenter radio-multiomic analysis for predicting breast cancer outcome and unravelling imaging-biological connection	21
Potential utility of risk stratification for multicancer screening with liquid biopsy tests	21
APOE-high myeloid cells are uniquely associated with metastatic intrathoracic lymph nodes obtained by EBUS-TBNA in primary lung cancer	21
HER2 expression in cervical squamous cell carcinoma: high prevalence of HER2-low/ultralow and spatiotemporal heterogeneity across tumor evolution	20
Novel paediatric case of a spinal high-grade astrocytoma with piloid features in a patient with Noonan Syndrome	20
Evaluating cell culture reliability in pediatric brain tumor primary cells through DNA methylation profiling	20
Personalized circulating tumor DNA dynamics inform survival and response to immune checkpoint blockade in recurrent/metastatic head and neck cancer	20
Complete response to fifth-line anti-PD-1 rechallenge in fumarate hydratase-mutated papillary renal cell carcinoma	20
Machine learning-driven multi-targeted drug discovery in colon cancer using biomarker signatures	20
Use of PSMA PET/CT to detect prostate cancer metastatic to a preexisting thyroid nodule	20
GD2: hopes and challenges for the treatment of pediatric patients with tumors of the central nervous system	20
Real life outcome analysis of breast cancer brain metastases treated with Trastuzumab Deruxtecan	20
Multi-omics analyses reveal interactions between GREM1+ fibroblasts and SPP1+ macrophages in gastric cancer	19
Imaging immunity in patients with cancer using positron emission tomography	19
Tertiary lymphoid structures potentially promote immune checkpoint inhibitor response in SMARCB1-deficient medullary renal cell carcinoma	19
Comprehensive characterization and targeted treatment of a pediatric epithelioid glioblastoma with a rare TRIM24-NTRK2 fusion	19
Predicting survival in prospective clinical trials using weakly-supervised QSP	19
AI-driven multi-omics integration of cancer-associated fibroblasts for prognostic modeling and therapeutic target discovery in head and neck squamous cell carcinoma	19
Opportunities and challenges for patient-derived models of brain tumors in functional precision medicine	18
Design of self-assembled micelles based on natural dual-targeting strategies and evaluation of their anti-liver cancer effects as drug delivery systems	18
Bladder cancer diagnostic and prognostic models from DNA methylation by multi algorithm machine learning	18
Author Correction: Predicting the tumor microenvironment composition and immunotherapy response in non-small cell lung cancer from digital histopathology images	18
Integrative analysis of KEAP1/NFE2L2 alterations across 3600+ tumors reveals an NRF2 expression signature as a prognostic biomarker in cancer	18
A review of machine learning methods for cancer characterization from microbiome data	18
Development of potent antibody drug conjugates against ICAM1+ cancer cells in preclinical models of cholangiocarcinoma	18

HDAC6 facilitates LUAD progression by inducing EMT and enhancing macrophage polarization towards the M2 phenotype	18
The drug efficacy testing in 3D cultures platform identifies effective drugs for ovarian cancer patients	18
Whole-genome analysis of an aggressive metastatic pancreatic solid pseudopapillary neoplasm	18
NCT/DKFZ MASTER handbook of interpreting whole-genome, transcriptome, and methylome data for precision oncology	18
Tackling FGFR3-driven bladder cancer with a promising synergistic FGFR/HDAC targeted therapy	17
Impact of TP53 mutations in Triple Negative Breast Cancer	17
Towards precision radiation oncology: endocrine therapy response as a biomarker for personalization of breast radiotherapy	17
Progress and challenges of artificial intelligence in lung cancer clinical translation	17
Element-specific estimation of background mutation rates in whole cancer genomes through transfer learning	17
Exceptional response to the ATR inhibitor, camonsertib, in a patient with ALT+ metastatic melanoma	17
A destabilizing Y891D mutation in activated EGFR impairs sensitivity to kinase inhibition	17
Single-cell transcriptome analysis identifies MIF as a novel tumor-associated neutrophil marker for pancreatic ductal adenocarcinoma	16
DNA methylation at quantitative trait loci (mQTLs) varies with cell type and nonheritable factors and may improve breast cancer risk assessment	16
Integrative whole slide image and spatial transcriptomics analysis with QuST and QuPath	16
Biallelic EPCAM deletions induce tissue-specific DNA repair deficiency and cancer predisposition	16
A comprehensive analysis of minimally differentially methylated regions common to pediatric and adult solid tumors	16
A phase II trial of mTORC1/2 inhibition in STK11 deficient non small cell lung cancer	16
Plasma epigenomic profiling reveals treatment-emergent squamous transformation in prostate cancer	16
Multimodal spatial proteomic profiling in acute myeloid leukemia	16
HAPIR: a refined Hallmark gene set-based machine learning approach for predicting immunotherapy response in cancer patients	15
Pre-radiotherapy ctDNA liquid biopsy for risk stratification of oligometastatic non-small cell lung cancer	15
Single-cell transcriptome sequencing reveals spatial distribution of IL34+ cancer-associated fibroblasts in hepatocellular carcinoma tumor microenvironment	15
An appraisal of genetic testing for prostate cancer susceptibility	15
Spatial tumor immune microenvironment phenotypes in ovarian cancer	15
Secrets of DNA-PKcs beyond DNA repair	15
Single-cell analysis of gastric pre-cancerous and cancer lesions reveals cell lineage diversity and intratumoral heterogeneity	15
Prediction and analysis of tumor infiltrating lymphocytes across 28 cancers by TILScout using deep learning	15
Defining the extracellular matrix for targeted immunotherapy in adult and pediatric brain cancer	15
Author Correction: Naltriben promotes tumor growth by activating the TRPM7-mediated development of the anti-inflammatory M2 phenotype	15
Deep learning-based detection and semi-quantitative model for spread through air spaces (STAS) in lung adenocarcinoma	15
Precision immuno-oncology approach for four malignant tumors in siblings with constitutional mismatch repair deficiency syndrome	15
Comprehensive genetic profiling and molecularly guided treatment for patients with primary CNS tumors	15
High risk clear cell renal cell carcinoma microenvironments contain protumour immunophenotypes lacking specific immune checkpoints	15
Large scale quantification of natural killer cell-induced apoptosis in patient-derived organoids reveals intratumoral response heterogeneity	15
Plasma cell-free DNA methylation-based prognosis in metastatic castrate-resistant prostate cancer	15
Single-cell spatial architectures associated with clinical outcome in head and neck squamous cell carcinoma	15
Multi-omics analysis reveals NNMT as a master metabolic regulator of metastasis in esophageal squamous cell carcinoma	15
Integrative molecular analyses define correlates of high B7-H3 expression in metastatic castrate-resistant prostate cancer	15
Multi-omics analysis deciphers intercellular communication regulating oxidative stress to promote oral squamous cell carcinoma progression	15
Fast, accurate, and racially unbiased pan-cancer tumor-only variant calling with tabular machine learning	15
Latent class analysis-derived classification improves the cancer-specific death stratification of molecular subtyping in colorectal cancer	14
Identification of novel prognostic and predictive biomarkers in salivary duct carcinoma via comprehensive molecular profiling	14
Upregulation of POLE and proficient DNA repair are features of CIC::DUX4 sarcomas	14
All models are wrong and yours are useless: making clinical prediction models impactful for patients	14
Integrative machine learning-driven prognosis and immunotherapy stratification via lactylation-associated gene in ovarian cancer	14
Trans-ancestry transcriptome-wide association and functional studies to uncover novel susceptibility genes and therapeutic targets for colorectal cancer	14
Complete response to alectinib in ALK-fusion metastatic salivary ductal carcinoma	14
Integration of pre-treatment computational radiomics, deep radiomics, and transcriptomics enhances soft-tissue sarcoma patient prognosis	14
Methylation cytometric pretreatment blood immune profiles with tumor mutation burden as prognostic indicators for survival outcomes in head and neck cancer patients on anti-PD-1 therapy	14
Integrating histopathology and transcriptomics for spatial tumor microenvironment profiling in a melanoma case study	14
Revealing neuroendocrine transformation in gynecological cancers through genomic analysis	14
Emerging innovations in theranostics for pancreatic neuroendocrine tumors	14
Collision of germline POLE and PMS2 variants in a young patient treated with immune checkpoint inhibitors	14
RadGLO: an interactive platform for radiomic feature analysis and prognostic modeling in glioma	14
GLMP promotes EGFR-TKI resistance by activating autophagy and RhoA pathway in non-small cell lung cancer	14
CAR-macrophages in solid tumors: promise, progress, and prospects	14
Accurate prediction of disease-free and overall survival in non-small cell lung cancer using patient-level multimodal weakly supervised learning	14
Cell graph neural networks enable the precise prediction of patient survival in gastric cancer	14
Genomic landscape of liquid biopsy mutations in TP53 and DNA damage genes in cancer patients	14
Survival-inferred fragility of statistical significance in phase III oncology trials	14
Author Correction: An interpretable machine learning system for colorectal cancer diagnosis from pathology slides	14
MC1R signaling through the cAMP-CREB/ATF-1 and ERK-NFκB pathways accelerates G1/S transition promoting breast cancer progression	13
Unsupervised generative AI for enhancing brain tumor segmentation in multi-center, incomplete real-world data scenarios	13
A multiparameter liquid biopsy approach allows to track melanoma dynamics and identify early treatment resistance	13
FUT3 mediated GRP78 fucosylation promotes colorectal cancer survival and proliferation under glucose restriction via PERK/ATF4/STC2 axis	13
Illuminating the future of precision cancer surgery with fluorescence imaging and artificial intelligence convergence	13
A machine learning-based framework for prognostic prediction and tumor microenvironment characterization of locally advanced cervical cancer with concurrent chemoradiotherapy	13
Image-based explainable artificial intelligence accurately identifies myelodysplastic neoplasms beyond conventional signs of dysplasia	13
Adaptive Darwinian off-target resistance mechanisms to selective RET inhibition in RET driven cancer	13
Enhancing decision-making in glioblastoma surgery through an explainable human-AI collaboration: an international multicenter model development and external validation study	13
Bayesian risk prediction model for colorectal cancer mortality through integration of clinicopathologic and genomic data	13
Short cold atmospheric plasma treatment preserves vascular quiescence in 3D tumor-stroma-endothelial models of pancreatic cancer in vitro and in ovo	13
Challenges and opportunities associated with the MD Anderson IMPACT2 randomized study in precision oncology	13
A morphometric signature to identify ductal carcinoma in situ with a low risk of progression	13
Prediction of early-stage melanoma recurrence using clinical and histopathologic features	13
Androgen receptor splice variant expression and prostate cancer recurrence after salvage therapy	13
ADNEX-AI: automated extraction of ultrasound predictors for interpretable ovarian cancer risk stratification	13
Locoregional tumor burden and risk of mortality in metastatic breast cancer	13
Neoadjuvant therapy-induced immune dynamics and myeloid-associated resistance in advanced head and neck cancer	13
Proximity of immune and tumor cells underlies response to BRAF/MEK-targeted therapies in metastatic melanoma patients	12
RNF4 mediated degradation of PDHA1 promotes colorectal cancer metabolism and metastasis	12
Intraoperative margin assessment for basal cell carcinoma with deep learning and histologic tumor mapping to surgical site	12
Comprehensive analysis of angiogenesis pattern and related immune landscape for individual treatment in osteosarcoma	12
Integrated drug resistance and leukemic stemness gene-expression scores predict outcomes in large cohort of over 3500 AML patients from 10 trials	12
Role of GPX3+ astrocytes in breast cancer brain metastasis activated by circulating tumor cell exosomes	12
A deep learning model, NAFNet, predicts adverse pathology and recurrence in prostate cancer using MRIs	12
Immunologic correlates in a CIC::DUX4 fusion-positive sarcoma responsive to dual immune checkpoint blockade	12
M6A-ALKBH5-dependent RBMS3-AS3 down-regulation suppresses ferroptosis to promote lung adenocarcinoma progression through HNRNPDL/ZEB1/GPX4 axis	12
A multi-modal deep learning model for prediction of Ki-67 for meningiomas using pretreatment MR images	12
Molecular landscape of ERBB2 alterations in 3000 advanced NSCLC patients	12
Quantitative ultrasound imaging for predicting response and guiding personalized neoadjuvant chemotherapy in breast cancer: randomized phase 2 clinical trial results	12
Improving diagnostic accuracy in preoperative glioma classification: performance of knowledge-enhanced large language models compared with radiologists	12
Biopsy image-based deep learning for predicting pathologic response to neoadjuvant chemotherapy in patients with NSCLC	12
Sotorasib resistance in KRAS G12C-mutant invasive mucinous adenocarcinoma with implications for VEGF-A	12
Refined high-content imaging-based phenotypic drug screening in zebrafish xenografts	12